Donald Trump hospital covid-19 prevention Donald Trump

Monoclonal antibodies for COVID-19: What do we know so far?

Reading now: 335
www.medicalnewstoday.com

Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regulatory agencies around the world are evaluating monoclonal antibodies for use as a therapy to treat COVID-19.Monoclonal antibodies gained media attention with the news in October 2020 that Donald Trump had received the experimental Regeneron antibody treatment.

They have since progressed to allow more widespread use. Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.This article provides an overview of the current state of monoclonal antibodies for COVID-19 treatment.Medical News Today also reached out to Dr.

Read more on medicalnewstoday.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA